Company Acro Biomedical Co., Ltd. Other OTC
Equities
ACBM
US0048921052
Food Processing
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Cordyceps Related Products
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -45.01% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Taiwan and Hong Kong
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -45.01% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 17-01-29 |
Shi Ming Li
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jer Li Lin
CTO | Chief Tech/Sci/R&D Officer | - | - |
Shi Tao Li
CTO | Chief Tech/Sci/R&D Officer | - | - |
Cheng Hsiang Kao
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 17-01-29 |
Cheng Hsiang Kao
PRN | Corporate Officer/Principal | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 60,042,000 | 30,042,000 ( 50.03 %) | 0 | 50.03 % |
Company contact information
Acro Biomedical Co. Ltd.
12175 Visionary Way Suite 1160
46038, Fishers
+
Sector
1st Jan change | Capi. | |
---|---|---|
+16.16% | 8.15B | |
+3.59% | 7.52B | |
+11.45% | 6.65B | |
-7.15% | 3.73B | |
-6.11% | 3.72B | |
+1.10% | 1.31B | |
+15.20% | 972M | |
-36.30% | 958M | |
-16.77% | 876M |